Delivering macrolide antibiotics to heal a broken heart - And other inflammatory conditions.

ABSTRACT: Drug carriers to deliver macrolide antibiotics, such as azithromycin, show promise as antibacterial agents. Macrolide drug carriers have largely focused on improving the drug stability and pharmacokinetics, while reducing adverse reactions and improving antibacterial activity. Recently, macrolides have shown promise in treating inflammatory conditions by promoting a reparative effect and limiting detrimental pro-inflammatory responses, which shifts the immunologic setpoint from suppression to balance. While macrolide drug carriers have only recently been investigated for their ability to modulate immune responses, the previous strategies that deliver macrolides for antibacterial therapy provide a roadmap for repurposing the macrolide drug carriers for therapeutic interventions targeting in

SUBMITTER: Venditto VJ 

PROVIDER: S-EPMC9063468 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature